retatrutide diabetes trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 What is Retatrutide? Key Facts

Description

Current findings suggest that Retatrutide is generally well-tolerated over extended periods when used under proper supervision

Adding insulin to current antihyperglycemic therapy All individuals starting insulin should receive education on the prevention and management of hypoglycemia [Grade D, Consensus]

STAR Protoc 2:100504 Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities

Tips for Managing Side Effects Eat smaller, more frequent meals Avoid fatty, greasy, or heavily processed foods Stay well hydrated Support your gut health with fiber and probiotics Communicate with your provider about symptom severity Important Safety Information The prescribing information includes a boxed warning about the risk of thyroid C-cell tumors, based on animal studies